Cortex Pharmaceuticals Inc.: The Irvine drug development...

Cortex Pharmaceuticals Inc.: The Irvine drug development company said it lost $4.2 million, or 64 cents a share, for the fiscal year ended June 30, compared with a net loss of $6.8 million, or $1.13 a share, for the prior fiscal year. For the fourth quarter, the company posted a net loss of $988,706, or 14 cents a share, compared to a net loss of $2.6 million, or 43 cents a share, for the 1995 quarter. No revenue was reported.